DOCSLIB.ORG

UC San Francisco Electronic Theses and Dissertations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
UC San Francisco Electronic Theses and Dissertations UCSF UC San Francisco Electronic Theses and Dissertations Title Identification and exploration of apoptotic and caspase proteolytic substrates. Permalink https://escholarship.org/uc/item/86t0d35v Author Seaman, Julia Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California ii Dedication To my husband, Nate, and my family, Mom, Dad and Chris. iii Acknowledgements I am very grateful for the advice, assistance and support from the Wells Lab. My advisor, Jim Wells, has created a wonderful laboratory environment for collaborative research and friendships. The lab, and members in it, could not have survived without the innumerable skills of Marja Tarr. My graduate career has been greatly assisted by sharing the experiences with fellow students Ashley Smart and Charlie Morgan in the lab. It has been fun to explore science and solve the big and small problems with them and the other graduate students in lab- Justin Rettenmaier, Hai Tran, Sam Pollock, and Alex Martinko. I have relied heavily on everyone else who counts himself or herself as a Wellsome member. The postdocs- especially Kazu Shimbo, Nick Agard, Arun Wiita, Jason Porter, Juan Diaz, JT Koerber, Nathan Thomsen, Duy Ngyuen, Peter Lee, Min Zhuang, Zach Hill and Olivier Julien- have helped improved my scientific skills and graduate school experience throughout my time in the lab. Finally, my scientific work relies heavily on many members who came before me. UCSF has been a great environment to learn and explore during my PhD. I am very thankful my program, PSPG and its staff- Deana Kroetz, Debbie Acoba and Rebecca Brown. The PSPG program also introduced me to my classmates who have helped relieve the stress of science throughout the years. Additionally, working at UCSF has exposed me to a great many number of core facilities and collaborators who have contributed to all facets of my work. First, I would like to thank the Mass Spectrometry Facility and its team under Al Burlingame, especially Dave Maltby and Robert Chalkley. I have also have worked with the Preclinical Therapeutic Core under Byron Hann and Don Hom and the MMTI with Blake Aftab. Finally, I would like to thank, Seth Ginsberg and Louis Tharp of the Global Healthy Living Foundation, for their fellowship and guidance. iv Abstract Apoptosis, a type of programmed cell death, is a universal and essential cellular function. There are numerous homeostatic biological roles of apoptosis and many diseases have or cause mys- or dis- regulated apoptosis, most notably cancer’s escape from apoptotic signals. Apoptosis has many distinctive characteristics including membrane blebbing, chromatin condensation, and most importantly for these studies, the activation of a class of protease proteins called caspases. Caspases are cysteine aspartic proteases with a unique preference to cleave hundred of substrates after acidic residues, especially aspartate. These cleavage events can activate, modify, or inhibit the substrate’s function, which leads to the dismantling of the cell during apoptosis. This process is well conserved throughout metazoan evolution, with parallel pathways in coral, fish, flies, worms and mice. To study apoptotic protease activity, the Wells Lab has developed a proteomic-based technique. This technique is an unbiased positive enrichment labeling mass spectrometry protocol. While the protocol was developed for studying caspase substrates during apoptosis in human cell culture, it is very versatile, allowing for use in almost any protein sample like perturbed cellular lysates, different species and primary samples. Chapter 1 covers the protocol specifics and uses, summarizing a decade’s worth of optimization and application. The DegraBase is the compilation of 44 different experiments using the N-terminal labeling method to examine apoptotic proteolytic activity described in Chapter 2. While much of the experimentation work was completed before I started the project, I completed compilation and standardization of raw data, and worked with Emily Crawford on the analysis. This global analysis reveals there is a large increase in proteolytic activity after apoptotic induction, and caspases account for 25% of the newly created fragments. Within caspase substrates, there is no v single biological process or sub-cellular location that is targeted, as caspases appear to cleave substrates throughout all the different pathways of the cell. Additionally, this database is also a good resource for endogenous proteolysis, including free methionines, and signal and transis peptide processing. Analysis of the DegraBase also reveals evolutionary and biological discoveries. As the apoptotic pathway to activate caspases is highly conserved throughout metazoans, we wanted to investigate the conservation of caspase substrates. In Chapter 3, the comparison of caspase substrates in worm, fly, mouse and human reveals a hierarchal structure. My contribution includes the murine dataset and comparison analysis in collaboration with Emily Crawford. We found caspase cleavage is highly conserved at the pathway level, while individual targets and sites are not as well conserved the more distant the animals. The unbiased and large size of the DegraBase also reveals broader caspase activity than previously described. Caspases had been assumed to have absolute specificity for aspartate and no activity for glutamate. However, with the large dataset, in Chapter 4, I reveal significant activity after glutamate and even potential activity after phosphoserine. This activity is verified through biochemical assays and x-ray crystallography, and expands the number of apoptotic caspase substrates by 15%. As many chemotherapeutics induce apoptosis, apoptotic, especially caspase, proteolytic substrates may be good biomarkers of treatment efficacy. The development of mouse models and a positive control are discussed in Chapter 5. These models utilize the DegraBase and labeling technology to identify peptides enriched in the blood and tumor specific to treatment responding mice as potential biomarkers. vi Table of Contents Chapter 1 1 Global analysis of cellular proteolysis by selective enzymatic labeling of protein N-termini References 40 Chapter 2 44 The DegraBase: a database of proteolysis in healthy and apoptotic human cells References 77 Chapter 3 86 Conservation of caspase substrates across metazoans suggests hierarchical importance of signaling pathways over specific targets and cleavage site motifs in apoptosis. References 118 Chapter 4 123 Cacidases: caspases can cleave after aspartate, glutamate and phosphoserine residues References 154 Chapter 5 169 Initial results and development of tools to identify apoptotic as biomarkers of chemotherapeutic efficacy References 204 vii List of Tables Chapter 1 Table 1 6 A summary of current methods for proteolytic cleavage site and substrate identification. Chapter 2 Table 1 71 P1’ amino acid frequency and Arg/N-End Rule Pathway half-lives Supplementary Tables 85 Chapter 3 Table 1 99 Summary of results Table 2 111 Fly and worm substrates with no human ortholog Supplementary Tables 122 Chapter 4 Table 1 128 Enrichment of P1 position amino acids Table 2 129 High conservation in mouse and human of P1 aspartate and glutamate cleavage sites and protein targets Table 3 134 Summary of kinetic values for cleavage of P1 aspartate and glutamate by caspases-3 and -7 Table 4 139 Enrichment of annotated phosphorylation sites observed cleaved Table 5 143 Summary of kinetic values for cleavage after aspartate, glutamate or phospho-serine Supplementary Tables 158 Chapter 5 Table 1 180 Proteins with peptides that were enriched for Study I Table 2 184 Proteins with peptides that were enriched for Study II Table 3 190 Enriched peptides Table 4 191 Proteins with peptides that were enriched for Study IV viii List of Figures Chapter 1 Figure 1 9 An overview of the subtiligase N-terminal labeling method Figure 2 11 A schematic difference between Forward and Reverse experiments Figure 3 16 Monitoring Apoptosis and Proteomic Distribution of Cleavage Substrates Figure 4 28 Selected Reaction Monitoring (SRM) for proteolytic substrate quantification Figure 5 31 Monitoring kinetics of recombinant caspase cleavage Figure 6 33 Plasma N-terminomics Figure 7 37 Sequence features of identified N-termini Chapter 2 Figure 1 48 Experimental schema, database design and database summary Figure 2 56 Venn diagrams show a larger overlap of unique protein and peptide identifications between untreated, apoptotic and apoptotic caspase-cleaved datasets Figure 3 59 IceLogo diagrams of untreated, apoptotic and caspase-cleaved datasets Figure 4 60 Proteolytic processing within datasets Figure 5 62 IceLogos for processing around the initiator methionine Figure 6 65 Mitochondrial and signal peptides within the untreated dataset Figure 7 68 Filled logos for endoproteolysis occurring at residue 66 or above Supplementary Figures 80 Chapter 3 Figure 1 90 Experimental scheme Figure 2 95 IceLogos and Secondary Structures for Human, Mouse, Fly and Worm cleavages Figure 3 98 Data analysis pipeline Figure 4 101 Comparison of sites and sequences ix Figure 5 107 Conservation hierarchy of caspase substrates Supplementary Figure 121 Chapter 4 Figure 1 132 IceLogos of aspartate and glutamate at P1 Figure 2 137 Crystal stuctures of caspase -3 and -7 with glutamate Figure 3 140 Cleavage of P1-phosphoserine by caspase-3 Figure 4 144 P1 aspartate and glutamate cleavage sites are not strongly
Load more

Recommended publications
  • N-Degradomic Analysis Reveals a Proteolytic Network Processing the Podocyte Cytoskeleton
    BRIEF COMMUNICATION www.jasn.org N-Degradomic Analysis Reveals a Proteolytic Network Processing the Podocyte Cytoskeleton †‡ † | † Markus M. Rinschen,* § Ann-Kathrin Hoppe,* Florian Grahammer, ¶ Martin Kann,* † † † †‡ Linus A. Völker,* Eva-Maria Schurek,* Julie Binz,* Martin Höhne,* § Fatih Demir,** | †† † ‡‡ Milena Malisic,** Tobias B. Huber, ¶ Christine Kurschat,* Jayachandran N. Kizhakkedathu, †‡ †‡ Bernhard Schermer,* § Pitter F. Huesgen,** and Thomas Benzing* § *Department II of Internal Medicine, †Center for Molecular Medicine Cologne (CMMC), ‡Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), and §Systems Biology of Ageing Cologne (Sybacol), BRIEF COMMUNICATION University of Cologne, Cologne, Germany; |Department of Medicine III, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ¶Department of Medicine IV, Medical Center and Faculty of Medicine – University of Freiburg, Freiburg, Germany; **Central Institute for Engineering, Electronics and Analytics, ZEA-3, Forschungszentrum Jülich, Jülich, Germany; ††BIOSS Centre for Biological Signalling Studies and Center for Biological Systems Analysis (ZBSA), Albert-Ludwigs-University, Freiburg, Germany; and ‡‡Centre for Blood Research, Department of Pathology and Laboratory Medicine, Department of Chemistry, University of British Columbia, Vancouver, Canada ABSTRACT Regulated intracellular proteostasis, controlled in part by proteolysis, is essential in of these genes leads to altered signaling maintaining the integrity of podocytes
    [Show full text]
  • Caspase Substrates and Inhibitors
    Downloaded from http://cshperspectives.cshlp.org/ on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Caspase Substrates and Inhibitors Marcin Pore˛ba1, Aleksandra Stro´z˙yk1, Guy S. Salvesen2, and Marcin Dra˛g1 1Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, 50-370 Wrocław, Poland 2Program in Cell Death Research, Sanford-Burnham Medical Research Institute, La Jolla, California 92024 Correspondence: [email protected] Caspases are proteases at the heart of networks that govern apoptosis and inflammation. The past decade has seen huge leaps in understanding the biology and chemistry of the caspases, largely through the development of synthetic substrates and inhibitors. Such agents are used to define the role of caspases in transmitting life and death signals, in imaging caspases in situ and in vivo, and in deconvoluting the networks that govern cell behavior. Additionally, focused proteomics methods have begun to reveal the natural substrates of caspases in the thousands. Together, these chemical and proteomics technologies are setting the scene for designing and implementing control of caspase activity as appropriate targets for disease therapy. WHAT IT TAKES TO BE A CASPASE group, known as cysteine protease clan CD that he need to recycle scarce amino acids in early also contains the plant metacaspases (Vercam- Tbiotic environments required that proteases men et al. 2004), and mammalian and plant were among the first proteins to appear in the proteases of the legumain family (involved in most primitive replicating organisms. Since that specific processing events), the eukaryotic pro- distant origin, proteases have diversified into tease separase (required for sisterchromatid sep- every biological niche, occupied every cellular aration during mitosis), and the bacterial prote- and extracellular compartment, and are encod- ases clostripain and gingipain (Chen et al.
    [Show full text]
  • Full Text (PDF)
    BACK TO BASICS | PROTEASES IN LUNG DISEASE Protean proteases: at the cutting edge of lung diseases Clifford Taggart1, Marcus A. Mall2,3,4, Gilles Lalmanach5, Didier Cataldo6, Andreas Ludwig7, Sabina Janciauskiene8, Nicole Heath3,4,9, Silke Meiners10, Christopher M. Overall11, Carsten Schultz4,9, Boris Turk12 and Keren S. Borensztajn13,14 Affiliations: 1Airway Innate Immunity Research group (AiiR), Centre for Experimental Medicine, Queen’s University Belfast, UK. 2Dept of Translational Pulmonology, University of Heidelberg, Heidelberg, Germany. 3Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, Dept of Pediatrics, University of Heidelberg, Heidelberg, Germany. 4Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany. 5INSERM UMR1100 Centre d’Etude des Pathologies Respiratoires (CEPR), Equipe: Mécanismes Protéolytiques dans l’Inflammation, Université François Rabelais, Tours, France. 6Laboratory of Tumors and Development and Dept of Respiratory Diseases, University of Liege, Liege, Belgium. 7Inflammation Pharmacology Research Group, Institute of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany. 8Dept of Respiratory Medicine, a member of The German Center for Lung Research (DZL), Hannover Medical School, Hannover, Germany. 9European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. 10Comprehensive Pneumology Center (CPC), University Hospital, Ludwig- Maximilians University, Helmholtz Zentrum München, Member of the German Center for
    [Show full text]
  • Proteolytic Cleavage—Mechanisms, Function
    Review Cite This: Chem. Rev. 2018, 118, 1137−1168 pubs.acs.org/CR Proteolytic CleavageMechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification Theo Klein,†,⊥ Ulrich Eckhard,†,§ Antoine Dufour,†,¶ Nestor Solis,† and Christopher M. Overall*,†,‡ † ‡ Life Sciences Institute, Department of Oral Biological and Medical Sciences, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada ABSTRACT: Proteases enzymatically hydrolyze peptide bonds in substrate proteins, resulting in a widespread, irreversible posttranslational modification of the protein’s structure and biological function. Often regarded as a mere degradative mechanism in destruction of proteins or turnover in maintaining physiological homeostasis, recent research in the field of degradomics has led to the recognition of two main yet unexpected concepts. First, that targeted, limited proteolytic cleavage events by a wide repertoire of proteases are pivotal regulators of most, if not all, physiological and pathological processes. Second, an unexpected in vivo abundance of stable cleaved proteins revealed pervasive, functionally relevant protein processing in normal and diseased tissuefrom 40 to 70% of proteins also occur in vivo as distinct stable proteoforms with undocumented N- or C- termini, meaning these proteoforms are stable functional cleavage products, most with unknown functional implications. In this Review, we discuss the structural biology aspects and mechanisms
    [Show full text]
  • Protein TAILS: When Termini Tell Tales of Proteolysis and Function
    Available online at www.sciencedirect.com Protein TAILS: when termini tell tales of proteolysis and function 1,2,3 1,2,3 Philipp F Lange and Christopher M Overall Among the hundreds of posttranslational modifications, limited functions of bioactive proteins will be opaque and hence proteolysis, also known as processing, is special: It is hypotheses based on traditional shotgun analyses, may be irreversible, near ubiquitous, and by trimming peptide chains misleading or even worse, totally wrong. from their ends or cutting proteins into two, proteolysis forms shorter chains displaying new termini. The unique chemistry PTM of proteins constitutes a highly diverse and dynamic and location of a-amino-termini and carboxyl-termini in a regulatory layer affecting all aspects of a protein from protein engender special chemical and physical properties to a protein folding, localization, interaction and bioactivity protein. Hence, modification of protein termini is often to its stability and ultimately degradation. Therefore, each associated with new biological activities of a protein. We distinctly modified version of a protein, also called a protein highlight recent proteomic developments enabling high species, and not just the initial translated version, needs to throughput identification of protein termini. This has be considered as the functional units comprising the pro- revolutionized degradomics and protein characterization by teome [3]. The diversity of reversible and irreversible mapping the specificity of terminal modifications and of modifications as well as the extensive modification machin- proteases, and has been used to directly identify new protease ery [4] and the possibility of combinatorial effects substrates and molecular pathways altered by proteolysis.
    [Show full text]
  • Biochemical Characterization and Zinc Binding Group (Zbgs) Inhibition Studies on the Catalytic Domains of Mmp7 (Cdmmp7) and Mmp16 (Cdmmp16)
    MIAMI UNIVERSITY The Graduate School Certificate for Approving the Dissertation We hereby approve the Dissertation of Fan Meng Candidate for the Degree DOCTOR OF PHILOSOPHY ______________________________________ Director Dr. Michael W. Crowder ______________________________________ Dr. David L. Tierney ______________________________________ Dr. Carole Dabney-Smith ______________________________________ Dr. Christopher A. Makaroff ______________________________________ Graduate School Representative Dr. Hai-Fei Shi ABSTRACT BIOCHEMICAL CHARACTERIZATION AND ZINC BINDING GROUP (ZBGS) INHIBITION STUDIES ON THE CATALYTIC DOMAINS OF MMP7 (CDMMP7) AND MMP16 (CDMMP16) by Fan Meng Matrix metalloproteinase 7 (MMP7/matrilysin-1) and membrane type matrix metalloproteinase 16 (MMP16/MT3-MMP) have been implicated in the progression of pathological events, such as cancer and inflammatory diseases; therefore, these two MMPs are considered as viable drug targets. In this work, we (a) provide a review of the role(s) of MMPs in biology and of the previous efforts to target MMPs as therapeutics (Chapter 1), (b) describe our efforts at over-expression, purification, and characterization of the catalytic domains of MMP7 (cdMMP7) and MMP16 (cdMMP16) (Chapters 2 and 3), (c) present our efforts at the preparation and initial spectroscopic characterization of Co(II)-substituted analogs of cdMMP7 and cdMMP16 (Chapters 2 and 3), (d) present inhibition data on cdMMP7 and cdMMP16 using zinc binding groups (ZBG) as potential scaffolds for future inhibitors (Chapter 3), and (e) summarize our data in the context of previous results and suggest future directions (Chapter 4). The work described in this dissertation integrates biochemical (kinetic assays, inhibition studies, limited computational methods), spectroscopic (CD, UV-Vis, 1H-NMR, fluorescence, and EXAFS), and analytical (MALDI-TOF mass spectrometry, isothermal calorimetry) methods to provide a detailed structural and mechanistic view of these MMPs.
    [Show full text]
  • Proteolytic Cleavage—Mechanisms, Function, and “Omic
    Review Cite This: Chem. Rev. XXXX, XXX, XXX−XXX pubs.acs.org/CR Proteolytic CleavageMechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification Theo Klein,†,⊥ Ulrich Eckhard,†,§ Antoine Dufour,†,¶ Nestor Solis,† and Christopher M. Overall*,†,‡ †Life Sciences Institute, Department of Oral Biological and Medical Sciences, and ‡Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada ABSTRACT: Proteases enzymatically hydrolyze peptide bonds in substrate proteins, resulting in a widespread, irreversible posttranslational modification of the protein’s structure and biological function. Often regarded as a mere degradative mechanism in destruction of proteins or turnover in maintaining physiological homeostasis, recent research in the field of degradomics has led to the recognition of two main yet unexpected concepts. First, that targeted, limited proteolytic cleavage events by a wide repertoire of proteases are pivotal regulators of most, if not all, physiological and pathological processes. Second, an unexpected in vivo abundance of stable cleaved proteins revealed pervasive, functionally relevant protein processing in normal and diseased tissuefrom 40 to 70% of proteins also occur in vivo as distinct stable proteoforms with undocumented N- or C- termini, meaning these proteoforms are stable functional cleavage products, most with unknown functional implications. In this Review, we discuss the structural biology aspects and mechanisms of
    [Show full text]
  • Topfind 2.0—Linking Protein Termini with Proteolytic Processing and Modifications Altering Protein Function Philipp F
    Published online 18 November 2011 Nucleic Acids Research, 2012, Vol. 40, Database issue D351–D361 doi:10.1093/nar/gkr1025 TopFIND 2.0—linking protein termini with proteolytic processing and modifications altering protein function Philipp F. Lange1,2,3,*, Pitter F. Huesgen1,2,3 and Christopher M. Overall1,2,3,* 1Centre for Blood Research, 2Department of Oral Biological and Medical Sciences and 3Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada V6T 1Z3 Received August 26, 2011; Revised October 6, 2011; Accepted October 23, 2011 ABSTRACT INTRODUCTION The function and morphology of a cell is by and large Protein termini provide critical insights into the Downloaded from functional state of individual proteins. With recent carried out by its proteome, likewise, that of a tissue by advances in specific proteomics approaches to its cells and their proteomes. The functional state of the enrich for N- and C-terminomes, the global proteome, and hence a cell, is defined by the structures, interactions and post-translational modifications of the analysis of whole terminomes at a proteome-wide proteins present at any given time and place. Proteins scale is now possible. Information on the actual N- are synthesized as single polypeptide chains that have a http://nar.oxfordjournals.org/ and C-termini of proteins in vivo and any start represented by the amino (N-) terminus, and a post-translational modifications, including their carboxyl (C-) terminus forming its end. Protein termini generation by proteolytic
    [Show full text]
  • CLIPPER: an Add-On to the Trans-Proteomic Pipeline for the Automated Analysis of TAILS N-Terminomics Data
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library DOI 10.1515/hsz-2012-0269 Biol. Chem., 2012; 393(12): 1477–1483 Short Communication Ulrich auf dem Keller * and Christopher M. Overall CLIPPER: an add-on to the Trans-Proteomic Pipeline for the automated analysis of TAILS N-terminomics data Abstract: Data analysis in proteomics is complex and with conditions, which has been hampered until recently by the extra challenges involved in the interpretation of data the lack of appropriate technologies (Overall and Blobel , from N-terminomics experiments, this can be daunting. 2007 ). To address this limitation several novel proteom- Therefore, we have devised a rational pipeline of steps to ics methods for the system-wide discovery of protease approach N-terminomics data analysis in a statistically- substrates in complex biological samples have been based and valid manner. We have automated these steps introduced (auf dem Keller and Schilling , 2010 ; Impens in CLIPPER, an add-on to the Trans-Proteomic Pipeline et al. , 2010 ; Huesgen and Overall , 2012 ) in the subfield of (TPP). Applying CLIPPER to the analysis of N- terminomics proteomics that has come to be known as degradomics data generated by terminal amine isotopic labeling of (Lopez -Otin and Overall, 2002 ). substrates (TAILS) enables high confidence peptide to High throughput degradomics techniques aim for protein assignment, protein N-terminal characterization the enrichment and, ideally, relative quantification of and annotation, and for protease analysis readily allows N-terminal peptides in protease-treated and control protease substrate discovery with high confidence.
    [Show full text]
  • The Podocyte Protease Web: Uncovering the Gatekeepers of Glomerular Disease
    The Podocyte Protease Web: Uncovering the Gatekeepers of Glomerular Disease Markus M. Rinschen 1,2,3, Pitter F. Huesgen 4, Rachelle E. Koch 5 1 Department II of Internal Medicine, and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany 2 Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. 3 Center for Mass Spectrometry and Metabolomics, The Scripps Research Institute, La Jolla, CA, USA 4 Central Institute for Engineering, Electronics and Analytics, ZEA-3, Forschungszentrum Jülich, Jülich, Germany 5 Division of Graduate Medical Sciences, Boston University School of Medicine, Boston, MA Address correspondence to: [email protected], [email protected] Joseph-Stelzmann-Str. 26 50931 Cologne Germany Fax +49 221/478 1426623 This manuscript was accepted published online by the American Journal of Physiology- Renal Physiology on Sept. 19, 2018. The final version of the manuscript is available at: doi.org/10.1152/ajprenal.00380.2018 Abstract Proteases regulate glomerular physiology. The last decade has revealed a multitude of podocyte proteases that govern the glomerular response to numerous physical and biological cues. These proteases form a protein signaling web that generates stress stimuli and serves as a key controller of the glomerular microenvironment. Furthermore, both the extracellular and intracellular proteolytic networks are perturbed in focal segmental glomerulosclerosis, as well as hypertensive and diabetic nephropathy. The highly-intertwined podocyte protease web is accordingly an integrative part of the podocyte’s damage response and is reactive to a variety of chemical, mechanical, and metabolic cues. Novel mass-spectrometry based technologies will help to untangle this proteolytic network: functional readouts acquired from deep podocyte proteomics, single glomerular proteomics, and degradomics may expose unprecedented protease activity.
    [Show full text]
  • Comprehensive Analysis of Human Protein N-Termini Enables
    www.nature.com/scientificreports OPEN Comprehensive analysis of human protein N-termini enables assessment of various protein Received: 28 February 2017 Accepted: 9 June 2017 forms Published online: 26 July 2017 Jeonghun Yeom1,2, Shinyeong Ju1,3, YunJin Choi4, Eunok Paek 4 & Cheolju Lee1,2 Various forms of protein (proteoforms) are generated by genetic variations, alternative splicing, alternative translation initiation, co- or post-translational modifcation and proteolysis. Diferent proteoforms are in part discovered by characterizing their N-terminal sequences. Here, we introduce an N-terminal-peptide-enrichment method, Nrich. Filter-aided negative selection formed the basis for the use of two N-blocking reagents and two endoproteases in this method. We identifed 6,525 acetylated (or partially acetylated) and 6,570 free protein N-termini arising from 5,727 proteins in HEK293T human cells. The protein N-termini included translation initiation sites annotated in the UniProtKB database, putative alternative translational initiation sites, and N-terminal sites exposed after signal/transit/pro- peptide removal or unknown processing, revealing various proteoforms in cells. In addition, 46 novel protein N-termini were identifed in 5′ untranslated region (UTR) sequence with pseudo start codons. Our data showing the observation of N-terminal sequences of mature proteins constitutes a useful resource that may provide information for a better understanding of various proteoforms in cells. Te diversity of protein from a single gene is generated by several mechanisms, including co- or post-translational modifcation, alternative splicing and alternative translation initiation. Tese processes afect function, localiza- tion, or stability of the protein. In particular, there may be a signifcant disparity between N-terminal site pre- dicted at the gene level and the N-terminal status of the protein product.
    [Show full text]
  • Terminomics Methodologies and the Completeness of Reductive Dimethylation: a Meta-Analysis of Publicly Available Datasets
    proteomes Technical Note Terminomics Methodologies and the Completeness of Reductive Dimethylation: A Meta-Analysis of Publicly Available Datasets Mariella Hurtado Silva 1 , Iain J. Berry 1,2, Natalie Strange 1 , Steven P. Djordjevic 2 and Matthew P. Padula 1,* 1 Proteomics Core Facility and School of Life Sciences, Faculty of Science, University of Technology Sydney, Broadway NSW 2007, Australia; [email protected] (M.H.S.); [email protected] (I.J.B.); [email protected] (N.S.) 2 The ithree Institute, Faculty of Science, University of Technology Sydney, Broadway NSW 2007, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-403-838-981 Received: 16 January 2019; Accepted: 25 March 2019; Published: 29 March 2019 Abstract: Methods for analyzing the terminal sequences of proteins have been refined over the previous decade; however, few studies have evaluated the quality of the data that have been produced from those methodologies. While performing global N-terminal labelling on bacteria, we observed that the labelling was not complete and investigated whether this was a common occurrence. We assessed the completeness of labelling in a selection of existing, publicly available N-terminomics datasets and empirically determined that amine-based labelling chemistry does not achieve complete labelling and potentially has issues with labelling amine groups at sequence-specific residues. This finding led us to conduct a thorough review of the historical literature that showed that this is not an unexpected finding, with numerous publications reporting incomplete labelling. These findings have implications for the quantitation of N-terminal peptides and the biological interpretations of these data.
    [Show full text]